12/4/2023 0 Comments Ispeak 1906![]() A presentation from Robin Blankenbaker, Lifesciences Industry Lead at Siemens Digital Industries Software, will demonstrate a digital thread of data sources from R&D through commercial manufacturing. Most often, critical data resides in silos that are unmined or lack integration. One of the key challenges for any facility aiming for full connectivity is identifying and removing data silos. These solutions enable progress for the industry as a whole, with considerations for all aspects of development from raw material to the final product. Members of the Biophorum Technology Roadmapping and IT groups will share examples of where they are collaborating, and concrete examples of scalable solutions. To this end, ISPE has collaborated with Biophorum to present their Digital Technology Roadmap, which builds upon the Digital Plant Maturity Model, to set out challenges and identify the key enablers for organisations to unlock the potential of digitalization. The digital transformation track of the 2023 ISPE Biotechnology Conference aims to explore all aspects of this journey, providing case studies and tools for attendees to feel confident in taking the next step down the road of digitalisation, no matter where their starting point may be. In these situations, digitalisation is best described as a journey, requiring much more than investing in data infrastructure, digital tools, and robotics. Considering this, the substantial financial investment requires a strong value proposition and a compelling strategic vision of the “end goal” of digital transformation. The benefits gained from digitalisation are hard to envision when interim measures include scanning handwritten Batch Records as digital batch records are “too hard” to implement or having digital records printed out just to have a paper copy stored in an archive. Even when digital tools are introduced the experience isn’t always smooth, as it can be even more challenging to exist in a hybrid digital/paper world. ![]() Indeed, the highly regulated nature of the pharmaceutical industry has made the adoption of digital technologies significantly more complex. ![]() The day-to-day reality for many working in the industry is reliance on a paper-based record system, with great reluctance to move away from its familiarity and simplicity. However, for many organisations and facilities, being sold the advantages of digital twins, real-time predictive analytics, advanced robotics, and artificial intelligence, can feel like hearing a distant pipe dream. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |